Hereditary maculopathies consist of a diverse group of disorders that affect central vision, with variable degrees of degeneration of the macula and retinal pigment epithelium (RPE). Molecular genetics has become increasingly useful in terms of disease categorization, diagnosis, and prognosis. This issue summarizes clinical features, study results, prognoses, and current molecular genetic discoveries pertaining to the most common and well-understood hereditary maculopathies.
Upon completion of this Focal Points issue, you should be able to:
- Describe the clinical features and characteristic study findings of the most common hereditary maculopathies.
- Discuss the basic genetics and pathophysiology of hereditary maculopathies.
- Consider the impact of molecular genetics on the future treatment of hereditary maculopathies and other forms of macular degeneration.
Focal Points issues are practical, hands-on discussions of the clinical challenges you face daily. Each issue delivers high-quality, trusted ophthalmic information written and reviewed by leading experts. Subscribe to Focal Points and receive 12 issues a year in the print or interactive online format.
CME Credit
The American Academy of Ophthalmology designates this enduring material for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Once you have completed this Focal Points issue, please visit CME Central to review or claim your CME. After purchasing this product, you may access it at www.aao.org/myonlineproducts.
